Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 952 | 108 | 843 |
| Samples | 333 | 49 | 283 |
| Peptides | 233 | 33 | 206 |
Function
HAVCR1 · Hepatitis A virus cellular receptor 1
The protein encoded by this gene is a membrane receptor for both human hepatitis A virus (HHAV) and TIMD4. The encoded protein may be involved in the moderation of asthma and allergic diseases. The reference genome represents an allele that retains a MTTVP amino acid segment that confers protection against atopy in HHAV seropositive individuals. The protein is a receptor for multiple other viruses, including Ebola virus, Marburg virus, Dengue virus, and Zika virus and is a possible entry factor for SARS-CoV-2 and other coronaviruses. [provided by RefSeq, Sep 2021].
Isoforms & Proteins
3 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 206 amino-acid changes on canonical ENST00000523175 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in HAVCR1 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in HAVCR1 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Gastrointestinal Stromal Tumour | 0/0 0% | 6/133 5% |
| Acute Myeloid Leukemia | 3/90 3% | 0/0 0% |
| Endometrial Carcinoma | 3/42 7% | 13/612 2% |
| Melanoma | 3/210 1% | 45/1899 2% |
| Non-Small Cell Lung Carcinoma | 8/304 3% | 26/1390 2% |
| Osteosarcoma | 3/45 7% | 0/166 0% |
| Other Solid Cancers | 0/94 0% | 21/1515 1% |
| Squamous Cell Lung Carcinoma | 1/57 2% | 10/810 1% |
| Small Cell Lung Carcinoma | 0/9 0% | 9/752 1% |
| Colorectal Carcinoma | 4/143 3% | 32/3239 1% |
| Neuroendocrine Tumour | 5/154 3% | 1/577 0% |
| Glioma | 2/52 4% | 15/2127 1% |
| Gastric Carcinoma | 0/74 0% | 14/1809 1% |
| Head and Neck Carcinoma | 1/85 1% | 11/1574 1% |
| Thyroid Gland Carcinoma | 0/45 0% | 11/1592 1% |
| Cervical Carcinoma | 2/35 6% | 1/422 0% |
| Hepatocellular Carcinoma | 0/46 0% | 12/2210 1% |
| Other Sarcomas | 2/69 3% | 2/699 0% |
| Germ Cell Tumour | 0/25 0% | 1/169 1% |
| Esophageal Carcinoma | 0/23 0% | 4/769 1% |
| Esophageal Squamous Cell Carcinoma | 2/51 4% | 11/2550 0% |
| Bladder Carcinoma | 0/58 0% | 5/956 1% |
| Non-Cancerous | 0/104 0% | 4/830 0% |
| Ovarian Carcinoma | 0/109 0% | 4/998 0% |
| Breast Carcinoma | 4/144 3% | 8/3264 0% |
| Plasma Cell Myeloma | 1/44 2% | 0/305 0% |
| Pancreatic Carcinoma | 0/89 0% | 5/1611 0% |
| Prostate Carcinoma | 2/13 15% | 4/2105 0% |
| Biliary Tract Carcinoma | 0/54 0% | 2/950 0% |
| B-Cell Non-Hodgkins Lymphoma | 1/88 1% | 3/2534 0% |
Mutation Distribution
Where HAVCR1 is mutated · all tissues, split by cell line vs tissue
How many mutations in HAVCR1 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 52 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 952 mutations in HAVCR1
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|